{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:12:46Z","timestamp":1761894766819},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.3816\/clm.2003.n.012","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:05Z","timestamp":1221095405000},"page":"36-42","source":"Crossref","is-referenced-by-count":28,"title":["First-Line Treatment with Brief-Duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-Grade Non-Hodgkin's Lymphoma: Phase II Trial"],"prefix":"10.3816","volume":"4","author":[{"given":"John D.","family":"Hainsworth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharlene","family":"Litchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Ray","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys I.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jr. Carroll","family":"Scroggin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Anthony","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2003.n.012_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.012_bib2","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/0959-8049(94)90183-X","article-title":"Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate or high-grade histology","volume":"30A","author":"Bessel","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2003.n.012_bib3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.1988.6.12.1838","article-title":"The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma","volume":"6","author":"Vose","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0002-9343(87)90944-2","article-title":"Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma","volume":"83","author":"Solal-Celigny","year":"1987","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.n.012_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/bjc.1990.238","article-title":"Full-dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen","volume":"62","author":"Sonneveld","year":"1990","journal-title":"Br J Cancer"},{"key":"10.3816\/CLM.2003.n.012_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1200\/JCO.1992.10.2.228","article-title":"A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma","volume":"10","author":"Tirelli","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/oxfordjournals.annonc.a058106","article-title":"A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma","volume":"3","author":"Salvagno","year":"1992","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib8","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1200\/JCO.1993.11.11.2250","article-title":"In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P\/DOCE chemotherapy","volume":"11","author":"O'Reilly","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/1097-0142(19910315)67:6<1487::AID-CNCR2820670604>3.0.CO;2-S","article-title":"A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma","volume":"67","author":"McMaster","year":"1991","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.012_bib10","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1200\/JCO.1993.11.12.2362","article-title":"P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma","volume":"11","author":"Martelli","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib11","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/86.17.1346","article-title":"Effective, well-tolerated treatment of aggressive histology non-Hodgkin's lymphoma in the elderly: use of a combination regimen containing extended-schedule etoposide","volume":"8","author":"Young","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2003.n.012_bib12","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood.V97.10.2991","article-title":"Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: Results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO","volume":"97","author":"Mainwaring","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.012_bib13","first-page":"33","article-title":"Elderly aggressive histology non- Hodgkin's lymphoma: First-line VNCOP-B regimen experience in 350 patients","volume":"94","author":"Zinzani","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.012_bib14","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.012_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.012_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti- CD20 monoclonal antibody and CHOP chemotherapy","volume":"17","author":"Czuczman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib17","first-page":"771a","article-title":"Combined fludarabine, cyclophosphamide, and rituximab achieves a high complete remission rate as initial treatment for chronic lymphocytic leukemia","volume":"98","author":"Wierda","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.012_bib18","first-page":"268a","article-title":"Rituximab plus short duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma (NHL): a Minnie Pearl Cancer Research Network phase II trial","volume":"21","author":"Hainsworth","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.3816\/CLM.2003.n.012_bib20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1200\/JCO.1991.9.5.741","article-title":"Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced stage diffuse large-cell lymphoma","volume":"9","author":"O'Reilly","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib21","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1200\/JCO.1997.15.8.2945","article-title":"Elderly patients with aggressive non- Hodgkin's lymphoma: disease presentation, response to treatment, and survival: a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years","volume":"15","author":"Bastion","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.012_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.1998.16.1.27","article-title":"CHOP is the standard regimen in patients \u226570 years of age with intermediate-grade and high-grade non- Hodgkin' lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group","volume":"16","author":"Tirelli","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511700070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511700070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T22:59:39Z","timestamp":1545778779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511700070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S1526965511700070"],"URL":"https:\/\/doi.org\/10.3816\/clm.2003.n.012","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}